OMO. A. Maltseva

O. A. Maltseva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


O. A. Maltseva has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gastric subepithelial lesions as a complex clinical problem. Examples of the effectiveness of endoscopic ultrasound diagnostics

    by N.V. Prolom, O.D. Shevchenko, O.M. Babii, O.V. Zeleniuk, S.O. Tarabarov, I.M. Adamska, O.A. Maltseva

    Subepithelial lesions of the stomach include a group of diseases with different etiologies, without specific clinical symptoms, and pose a diagnostic problem due to their heterogeneous nature. As their name suggests, they arise under the mucosal layer, or from the muscularis mucosa, submucosa, or muscularis propria. Gastroduodenoscopy allows the detection of submucosal neoplasms of the gastrointestinal tract in 0.36–4 % of cases, while the stomach is the most frequent location of submucosal neoplasms (up to 60 %), so the main clinical problem is that conventional gastroscopy often does not allow determining from which layer of the wall the neoplasm originates, whether it is benign or has malignant potential, or whether surgical intervention is required. Currently, endoscopic ultrasonography (EUS) is the best tool for characterizing subepithelial lesions of the stomach and is the leading method for diagnosing submucosal tumors of the gastrointestinal tract, as it combines the capabilities of endoscopic visualization and high-frequency ultrasound. To choose further treatment tactics, it is important to determine from which layers the tumor originates, to what level it grows, and whether there is damage to regional lymph nodes. Endoscopic ultrasonography can answer these questions. The European Society of Gastrointestinal Endoscopy recommends EUS as the most informative method for diagnosing submucosal neoplasms to determine the features of subepithelial lesions of the esophagus, sto­mach, intestine, clarify the size, location, initial layer, echogenicity, shape and perform differential diagnosis of benign and malignant tumors (growth into adjacent layers or organs, da­mage to lymph nodes). The purpose of the work was to demonstrate the role of endoscopic ultrasound in the diagnosis of gastric subepithelial lesions. Subepithelial (submucosal) lesions of the stomach in most cases have an asymptomatic course and are often an incidental finding during esophagogastroduodenoscopy. Endo­scopic ultrasonography is the method of choice for the comprehensive assessment of subepithelial gastric neoplasms, as it allows determining the layer of origin of the tumor, its size, echogenicity, internal structure, contours, degree of vascularization and relationship to surrounding tissues. Additional use of compression elastography, contrast-enhanced endoscopic ultrasonography and EUS-guided fine-needle biopsy using modern needles significantly increases the accuracy of morphological verification and stratification of the risk of malignancy. The article presents clinical cases of patients evaluated for suspected gastric subepithelial lesions at the State Institution “Institute of Gastroente­rology of of the National Academy of Medical Sciences of Ukraine”. They demonstrate that the results of EUS directly influence the choice of treatment tactics. EUS confirmed the diagnosis of a gastric subepithelial lesion in both patients.

  • Open Access

    Impact of liver and pancreatic steatosis on behavioral responses in rats under experimental conditions and after cessation of combined exposure to steatogenic factors

    by A.M. Halinska, O.A. Maltseva, O.O. Halinskyi

    Background. Metabolically associated steatotic liver diseases are considered a multisystem phenotype of cardiometabolic risk with potential neurobehavioral consequences. Increasing attention is being paid to pancreatic steatosis as a manifestation of ectopic fat accumulation associated with insulin resistance and possible impairment of endocrine and exocrine functions. Combined models of high-fat, high-carbohydrate loading and chronic stress enable the reproduction of complex metabolic dysregulation and the assessment of systemic effects and their partial reversibility. The purpose: to evaluate the effect of alimentary-stress-induced steatosis on the behavioral activity of rats and to determine the features of natural recovery after cessation of the pathogenic influence. Materials and methods. The study was conducted on sexually mature male white laboratory rats (n = 31). The animals were divided into three groups: a control group (n = 8), a group with 60-day alimentary-stress modeling (n = 16), and a self-rehabilitation group, in which after 60 days of modeling, there was a 30-day recovery period without treatment (n = 7). Steatosis was induced by a steatogenic diet with an increased content of saturated fats (30 % of the energy value of the diet), a 10% aqueous fructose solution as the sole source of drinking fluid, and exposure to chronic stress caused by restriction of living space. Behavioral reactions were assessed using the Open Field and Elevated Plus Maze tests. The formation of liver and pancreatic steatosis was confirmed histologically. Normality of distribution was assessed using the Shapiro-Wilk test, and Welch’s t-test or the Mann-Whitney test was applied; at p < 0.05, the data were considered statistically significant. Results. After 60 days of alimentary-stress modeling of steatosis, rats exhibited a marked suppression of locomotor and exploratory activity: crossings of outer squares decreased from 32.25 ± 3.13 to 5.00 (3.00–10.50), the number of rearings from 12.81 ± 1.46 to 2.00 (1.00–4.00), and hole exploration acts from 21.19 ± 1.96 to 4.94 ± 0.73 (all p < 0.001). After 30 days of self-rehabilitation, total and vertical activity approached control values ((24.71 ± 4.18) crossings of outer squares; (12.57 ± 2.57) rearings; p > 0.05); however, hole exploration behavior remained significantly lower — 13.43 ± 2.32 versus 21.19 ± 1.96 (p = 0.02). In the Elevated Plus Maze test, changes were selective and mainly concerned anxiety-related cautious behavior and vertical responses: the number of head dips decreased from 13.19 ± 1.36 to 6.56 ± 1.38 (p < 0.001), and rearings from 7.31 ± 1.03 to 2.00 (0.75–2.25) (p < 0.001). In contrast, the number of arm entries and center crossings did not differ statistically from control va­lues (p > 0.05), which is consistent with the differing sensitivity of behavioral markers in this model. Conclusions. Alimentary-stress modeling induces morphologically confirmed steatotic changes in the liver and fatty infiltration of the pancreas and is accompanied by pronounced suppression of motor and exploratory activity with selective alterations in anxiety-related cautious behavior, while cessation of the steatogenic influence ensures partial recovery with persistence of certain exploratory impairments.

  • Open Access

    Chronic atrophic gastritis as a precancer: the evolution of ideas from the Sydney consensus to Maastricht VI

    by Yu. M. Stepanov, Yu. A. Haidar, O. A. Maltseva

    Aim. The purpose of the work is the evolution of systems and classifications of gastritis: Sydney Consensus (1990), Houston Modification (1994), OLGA/OLGIM (2008), Kyoto (2014), MAPS II (2019), Maastricht IV (2022). Materials and methods. During the work, 25 sources of information were used. Results. Chronic atrophic gastritis (ChAG) is a clinical and morphological diagnosis, and the presented clinical forms (types) of gastritis have characteristic morphological criteria. According to the Sydney system, changes in the antrum and body of the stomach are described separately. This has led to a lack of clear risk stratification criteria for CG and also complicates the objective analysis of regression of inflammation and atrophy. OLGA/OLGIM systems were proposed to determine the stage of atrophy and IM. The authors of the Kyoto consensus add and clarify the etiological section of ChAG. In MAPS II, ChAG and IM are considered precancerous conditions, as they increase the risk of developing gastric cancer and are the background for the occurrence of dysplasia and adenocarcinoma. For patients with dysplasia and the absence of visible changes in the mucous membrane, high-resolution endoscopy with staining is recommended. They should be examined after 6 months for a high degree of dysplasia and after 12 months for a low degree of dysplasia. Patients with IM and one localization have a high risk of developing gastric cancer. However, the high risk does not give the right to follow up in the majority of cases when high-quality endoscopy with biopsy does not show severe atrophy. Patients with IM of one location, with a family history of cancer, or with incomplete IM and persistence of H. pylori chromo endoscopy with biopsy must be done once every 3 years. Patients with extended fields of atrophic aggression (pronounced atrophic changes) or IM in the antrum and body, OLGA/OLGIM III/IV should be screened with chromoendoscopy with biopsy every 3 years. Patients with significant atrophy and familial cancer benefit from chromoendoscopy and biopsy every 1–2 years after initial diagnosis. Patients with autoimmune gastritis are recommended to be screened every 3–5 years. According to Maastricht VI, H. pylori is the main etiological factor of gastric adenocarcinoma, including proximal gastric cancer. Conclusions. After careful study and analysis, we came to the conclusion about the gradual development of the principles of evidence-based medicine in the issue of improving the clinical and morphological diagnosis of chronic atrophic gastritis as a precancerous of the stomach.